Investigator’s Brochure (IB)

Feb 28, 2025

What Does the ‘Investigator’s Brochure (IB)’ Mean?

An Investigator’s Brochure (IB) is a comprehensive document that summarizes the clinical and non-clinical data about an investigational product. It is provided to investigators and other key personnel involved in a clinical trial to inform them about the product’s properties, mechanism of action, and potential risks and benefits.

The IB serves as a crucial reference throughout the clinical development process. It contains information on pharmacology, toxicology, pharmacokinetics, and any available clinical data, helping investigators make informed decisions about patient safety and trial conduct.

Why Is the ‘Investigator’s Brochure (IB)’ Important in Clinical Research?

The Investigator’s Brochure (IB) is crucial in clinical research as it provides essential information for the safe and ethical conduct of clinical trials. It ensures that all investigators have access to the same comprehensive data about the investigational product, promoting consistency in trial procedures and decision-making across multiple study sites.

Furthermore, the IB plays a vital role in regulatory compliance and ethical review processes. It serves as a key document for Institutional Review Boards (IRBs) and regulatory authorities to assess the potential risks and benefits of a clinical trial, facilitating informed decisions about trial approval and participant safety.

Good Practices and Procedures

Establish a clear update schedule and version control system for the IB, ensuring all stakeholders always have access to the most current information.
Implement a structured review process involving multidisciplinary experts to validate the accuracy and completeness of IB content before distribution.
Develop a concise executive summary highlighting key changes for each IB update to facilitate quick review by investigators and ethics committees.
Maintain a comprehensive audit trail of IB revisions, including rationales for changes and approvals, to support regulatory inspections and transparency.
Create a secure, searchable electronic platform for IB distribution, allowing controlled access and real-time updates while ensuring data protection.